Literature DB >> 24475839

C-arm cone-beam CT-guided percutaneous transthoracic needle biopsy of lung nodules: clinical experience in 1108 patients.

Sang Min Lee1, Chang Min Park, Kyung Hee Lee, Young Eun Bahn, Jung Im Kim, Jin Mo Goo.   

Abstract

PURPOSE: To retrospectively evaluate the diagnostic performance and complications of C-arm cone-beam computed tomography (CT)-guided percutaneous transthoracic needle biopsy (PTNB) in 1108 patients.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board with waiver of patient informed consent. From January 2009 to December 2011, 1108 patients (633 male, 475 female; mean age, 62.4 years ± 12.3 [standard deviation]) with 1116 pulmonary lesions (mean size, 2.7 cm ± 1.7) underwent 1153 cone-beam CT-guided PTNBs. A coaxial system with 18-gauge cutting needles was used. Diagnostic performance, complication rate, influencing factors, and patient radiation exposure were investigated. Variables influencing diagnostic performance and complications were assessed by using uni- and multivariate logistic regression analyses.
RESULTS: Among 1153 PTNBs, pathologic analysis showed 1148 (99.6%) were technically successful (766 malignant [66.4%], 323 benign [28.0%], and 59 [5.1%] indeterminate). Sensitivity, specificity, and accuracy for diagnosis of malignancy were 95.7% (733 of 766), 100% (323 of 323), and 97.0% (1056 of 1089), respectively. In regard to diagnostic failures (five technical failures, 33 false-negative findings), lesions 1 cm in diameter or smaller and lesions in the lower lobe were significant risk factors (P = .028 and P = .034, respectively). As for complications, pneumothorax and hemoptysis occurred in 196 (17.0%) and 80 (6.9%) procedures, respectively. Multivariate analysis revealed two or more pleural passages and emphysema along the needle pathway were the two most significant risk factors for pneumothorax, and ground-glass nodules were the most significant risk factor for hemoptysis (P < .001 for all). Virtual guidance was a significant protective factor for both pneumothorax and hemoptysis (P < .001 for both). Mean estimated effective radiation dose through cone-beam CT-guided PTNBs was 7.3 mSv ± 4.1.
CONCLUSION: Cone-beam CT-guided PTNB is a highly accurate and safe technique with which to diagnose pulmonary lesions with reasonable radiation exposure. RSNA, 2013

Entities:  

Mesh:

Year:  2013        PMID: 24475839     DOI: 10.1148/radiol.13131265

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  82 in total

1.  Augmented Reality-Assisted Biopsy of Soft Tissue Lesions.

Authors:  Patric Bettati; Majid Chalian; James Huang; James D Dormer; Maysam Shahedi; Baowei Fei
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2020-03-16

2.  Risk factors of complications after CT-guided percutaneous needle biopsy of lumps near pulmonary hilum.

Authors:  Zhong-Yuan Yin; Zhen-Yu Lin; Ye Wang; Peng-Cheng Li; Nan Shen; Qiong Wang; Ting Ye; Zhen-Wei Zou; Bian Wu; Kun-Yu Yang; Gang Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

3.  C-Arm Cone-Beam CT Virtual Navigation-Guided Percutaneous Mediastinal Mass Biopsy: Diagnostic Accuracy and Complications.

Authors:  Hyungjin Kim; Chang Min Park; Sang Min Lee; Jin Mo Goo
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

4.  Comparison of cone-beam CT-guided and CT fluoroscopy-guided transthoracic needle biopsy of lung nodules.

Authors:  Nicola Rotolo; Chiara Floridi; Andrea Imperatori; Federico Fontana; Anna Maria Ierardi; Monica Mangini; Veronica Arlant; Giuseppe De Marchi; Raffaele Novario; Lorenzo Dominioni; Carlo Fugazzola; Gianpaolo Carrafiello
Journal:  Eur Radiol       Date:  2015-06-06       Impact factor: 5.315

Review 5.  The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer.

Authors:  Qinghua Zhou; Jingsi Dong; Jie He; Deruo Liu; David H Tian; Shugeng Gao; Shanqing Li; Lunxu Liu; Jianxing He; Yunchao Huang; Shidong Xu; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Lijie Tan; Danqing Li; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Zhentao Yu; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Roberto F Casal; Eugenio Pompeo; Angelo Carretta; Marc Riquet; Ottavio Rena; Pierre-Emmanuel Falcoz; Hisashi Saji; Ali Zamir Khan; Jose Luis Danguilan; Diego Gonzalez-Rivas; Nicolas Guibert; Chengchu Zhu; Jianfei Shen
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Rapid needle-out patient-rollover approach after cone beam CT-guided lung biopsy: effect on pneumothorax rate in 1,191 consecutive patients.

Authors:  Jung Im Kim; Chang Min Park; Sang Min Lee; Jin Mo Goo
Journal:  Eur Radiol       Date:  2015-02-01       Impact factor: 5.315

7.  Percutaneous needle biopsy of mediastinal masses under C-arm conebeam CT guidance: diagnostic performance and safety.

Authors:  Chiara Floridi; Alfonso Reginelli; Raffaella Capasso; Enrico Fumarola; Filippo Pesapane; Antonio Barile; Marcello Zappia; Ferdinando Caranci; Luca Brunese
Journal:  Med Oncol       Date:  2017-03-24       Impact factor: 3.064

8.  Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.

Authors:  Su Yeon Ahn; Soon Ho Yoon; Bo Ram Yang; Young Tae Kim; Chang Min Park; Jin Mo Goo
Journal:  Eur Radiol       Date:  2018-06-15       Impact factor: 5.315

Review 9.  Management of CT screen-detected lung nodule: the thoracic surgeon perspective.

Authors:  Adnan M Al-Ayoubi; Raja M Flores
Journal:  Ann Transl Med       Date:  2016-04

10.  Prospective Randomized Trial for Image-Guided Biopsy Using Cone-Beam CT Navigation Compared with Conventional CT.

Authors:  Nadine Abi-Jaoudeh; Teresa Fisher; John Jacobus; Marlene Skopec; Alessandro Radaelli; Imramsjah Martijn Van Der Bom; Robert Wesley; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2016-07-25       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.